Overview
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 18
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 5, 2024 | A New Era for Azenta: John P. Marotta Takes the Helm | Change is in the air at Azenta, Inc. The life sciences company is gearing up for a new chapter with the appointment of John P. Marotta as its President and CEO. This transition marks the end of an era under Dr. Stephen Schwartz, who has led... |
| Sep 4, 2024 | AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO | Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass., Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P. Marotta will join the Company ... |
| Aug 12, 2024 | GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event | BURLINGTON, Mass., Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ... |
| Aug 6, 2024 | Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024 | BURLINGTON, Mass., Aug. 6, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2024. Quarter Ended Dollars in millions, except per share data June 30, March 31, June 30, Cha... |
| Jul 24, 2024 | Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast | BURLINGTON, Mass., July 24, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes. The Company will host a confere... |
| Jun 4, 2024 | Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research | Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass., June 4, 2024 /PRNewswire/ -- Azent... |
| May 13, 2024 | Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK | BURLINGTON, Mass., May 13, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further i... |
| May 8, 2024 | Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024 | BURLINGTON, Mass., May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the second quarter ended March 31, 2024. Quarter Ended Dollars in millions, except per share data March 31, December 31, March 3... |
| May 8, 2024 | Azenta Announces CEO Succession Plan | CEO Dr. Stephen Schwartz to Retire; Search Underway to Identify Successor BURLINGTON, Mass., May 8, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a CEO succession plan, under which CEO and Board Director Dr. Stephen Schwa... |
Reviews 0
FAQ about Azenta Life Sciences
When was Azenta Life Sciences founded?
Azenta Life Sciences was founded in 1978.
How much funding has Azenta Life Sciences raised?
Azenta Life Sciences has raised $500M in total across 1 funding round.
What has the press written about Azenta Life Sciences?
Parsers VC has collected 18 articles mentioning Azenta Life Sciences, among them “A New Era for Azenta: John P. Marotta Takes the Helm” (Sep 5, 2024) and “AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO” (Sep 4, 2024).
Is Azenta Life Sciences still active?
Yes, Azenta Life Sciences is active; its latest activity on Parsers VC dates from Jul 13, 2026.